Advanced in Metabolic Syndrome

Dr. Norman Lepor

Cardiology
Westside Medical Imaging
99 N La Cienega Blvd Ste 103, 
Beverly Hills, CA 
Offers Telehealth

Advanced in Metabolic Syndrome
Westside Medical Imaging
99 N La Cienega Blvd Ste 103, 
Beverly Hills, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Norman Lepor is a Cardiologist in Beverly Hills, California. Dr. Lepor is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Angina, and High Cholesterol.

His clinical research consists of co-authoring 56 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Specialist in CA
Hospital Affiliations
Cedars-Sinai Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Westside Medical Imaging
99 N La Cienega Blvd Ste 103, Beverly Hills, CA 90211
Call: 310-289-9955

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2025
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Mixed Dyslipidemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: October 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Enrollment Status: Completed
Publish Date: October 03, 2025
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Enrollment Status: Terminated
Publish Date: December 13, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
VITROS Immunodiagnostic Products NT-proBNP II
VITROS Immunodiagnostic Products NT-proBNP II
Enrollment Status: Completed
Publish Date: March 09, 2020
Intervention Type: Diagnostic test
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study
Enrollment Status: Unknown
Publish Date: April 26, 2019
Intervention Type: Drug
Study Drug: Alirocumab
Study Phase: Phase 4
View 9 Less Clinical Trials

56 Total Publications

Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial.
Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial.
Journal: JAMA cardiology
Published: February 12, 2025
View All 56 Publications
Similar Doctors
Elite in Metabolic Syndrome
Dr. Matthew Budoff
Cardiology
Elite in Metabolic Syndrome
Dr. Matthew Budoff
Cardiology

Los Angeles Biomedical Research Institute At Harbor-UCLA Medical Cente

1124 W Carson St, 
Torrance, CA 
 (17.0 miles away)
310-222-2515
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Matthew Budoff is a Cardiologist in Torrance, California. Dr. Budoff is rated as an Elite provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Heart Attack, Hormone Replacement Therapy (HRT), and Heart Bypass Surgery.

Sam J. Kalioundji
Distinguished in Metabolic Syndrome
Dr. Sam J. Kalioundji
Cardiology | Interventional Cardiology
Distinguished in Metabolic Syndrome
Dr. Sam J. Kalioundji
Cardiology | Interventional Cardiology

Sam J. Kalioundji, MD Private Practice

18406 Roscoe Blvd, 
Northridge, CA 
 (13.9 miles away)
818-477-2337
Languages Spoken:
English, Arabic, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Sam Kalioundji (pronounced Kal-yoon-gee) was born and raised in the San Fernando Valley. He graduated in 2001 from the University of California, Los Angeles with a Bachelor’s Degree in Neuroscience. He then attended Medical School / Fifth Pathway at New York Medical College / Universidad Autonoma de Guadalajara. While in medical school, Dr. Kalioundji excelled in his medical coursework and diligently served the indigent with compassion. He graduated in 2007 as a Physician/Surgeon MD.In 2007, Dr. Kalioundji began his medical internship and residency at the University of Southern California. While building on his skills through the medical internship and residency program, he conducted extensive research on antiplatelet therapy and medical compliance. From 2010 to 2013, he completed his cardiology fellowship at USC/LAC.Dr. Kalioundji completed the Interventional Cardiology fellowship at Kaiser Los Angeles Medical Center in 2014. He received sub-specialty training in Interventional Cardiac and Peripheral Interventions with over 1500 cases performed, one of the highest in Southern California. He was nominated by his mentors as a Fellow to the American College of Cardiology (FACC).Dr. Kalioundji is Board Certified in Internal Medicine and Cardiology through the American Board of Internal Medicine. He is board eligible in Interventional Cardiology.Fluent in English, Spanish, and Arabic, Dr. Kalioundji enjoys traveling and sharing in experiences of different cultures. He has participated in numerous marathons and triathlons including the LA Marathon 9 times and counting. He is an Eagle Boy Scout and assists in numerous philanthropic causes. He truly believes in a sound mind in a sound body.Dr. Kalioundji is honored to join the practice of Dr. Elias under his esteemed mentorship.Spending quality time with each patient and their family to establish the best possible plan to improve the health of each and every one of his patients. Dr. Kalioundji is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Metabolic Syndrome, Angina, Pulmonary Edema, Pacemaker Implantation, and Endoscopy.

Distinguished in Metabolic Syndrome
Dr. Henry Yee
Cardiology
Distinguished in Metabolic Syndrome
Dr. Henry Yee
Cardiology

Long Life Cardiac Center Medical Corp.

35 S Garfield Ave, 
Alhambra,, CA 
 (14.4 miles away)
626-458-8818
Languages Spoken:
English
See accepted insurances

Henry Yee is a Cardiologist in Alhambra,, California. Dr. Yee is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Metabolic Syndrome, Angina, Coronary Heart Disease, Pacemaker Implantation, and Colonoscopy.

VIEW MORE METABOLIC SYNDROME DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lepor's expertise for a condition
ConditionClose
    • Distinguished
    • Angina
      Dr. Lepor is
      Distinguished
      . Learn about Angina.
      See more Angina experts
    • Atherosclerosis
      Dr. Lepor is
      Distinguished
      . Learn about Atherosclerosis.
      See more Atherosclerosis experts
    • Carotid Artery Disease
      Dr. Lepor is
      Distinguished
      . Learn about Carotid Artery Disease.
      See more Carotid Artery Disease experts
    • Coronary Heart Disease
      Dr. Lepor is
      Distinguished
      . Learn about Coronary Heart Disease.
      See more Coronary Heart Disease experts
    • High Cholesterol
      Dr. Lepor is
      Distinguished
      . Learn about High Cholesterol.
      See more High Cholesterol experts
    • Advanced
    • Aortic Regurgitation
      Dr. Lepor is
      Advanced
      . Learn about Aortic Regurgitation.
      See more Aortic Regurgitation experts
    • Arterial Embolism
      Dr. Lepor is
      Advanced
      . Learn about Arterial Embolism.
      See more Arterial Embolism experts
    • Atrial Fibrillation
      Dr. Lepor is
      Advanced
      . Learn about Atrial Fibrillation.
      See more Atrial Fibrillation experts
    • Fainting
      Dr. Lepor is
      Advanced
      . Learn about Fainting.
      See more Fainting experts
    • Familial Hypertension
      Dr. Lepor is
      Advanced
      . Learn about Familial Hypertension.
      See more Familial Hypertension experts
    • Glucocorticoid-Remediable Aldosteronism
      Dr. Lepor is
      Advanced
      . Learn about Glucocorticoid-Remediable Aldosteronism.
      See more Glucocorticoid-Remediable Aldosteronism experts
    View All 21 Advanced Conditions
    • Experienced
    • Adenosine Deaminase 2 Deficiency
      Dr. Lepor is
      Experienced
      . Learn about Adenosine Deaminase 2 Deficiency.
      See more Adenosine Deaminase 2 Deficiency experts
    • Aortic Valve Stenosis
      Dr. Lepor is
      Experienced
      . Learn about Aortic Valve Stenosis.
      See more Aortic Valve Stenosis experts
    • Apoplexy
      Dr. Lepor is
      Experienced
      . Learn about Apoplexy.
      See more Apoplexy experts
    • Arrhythmogenic Right Ventricular Cardiomyopathy
      Dr. Lepor is
      Experienced
      . Learn about Arrhythmogenic Right Ventricular Cardiomyopathy.
      See more Arrhythmogenic Right Ventricular Cardiomyopathy experts
    • Atrial Tachycardia
      Dr. Lepor is
      Experienced
      . Learn about Atrial Tachycardia.
      See more Atrial Tachycardia experts
    • Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
      Dr. Lepor is
      Experienced
      . Learn about Atrioventricular Nodal Reentrant Tachycardia (AVNRT).
      See more Atrioventricular Nodal Reentrant Tachycardia (AVNRT) experts
    View All 40 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.